[Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
Anna-Rebekka StaufenbergHanna K FrankenbergerUlrike Förster-RuhrmannFranziska C SpahnLudger KlimekKai FruthClemens StihlChristoph MatthiasMoritz GrögerJan HagemannPublished in: HNO (2024)
Add-on biologic therapy is effective, safe, and widely accepted among CRSwNP + NERD patients. Future studies might allow for personalized algorithms with sequential surgery, ATAD, and/or biologic therapy.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- newly diagnosed
- minimally invasive
- machine learning
- ejection fraction
- chronic kidney disease
- low dose
- prognostic factors
- type diabetes
- stem cells
- cardiovascular events
- deep learning
- patient reported outcomes
- acute coronary syndrome
- antiplatelet therapy
- cardiovascular disease
- atrial fibrillation
- drug induced